These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 19904236)
1. Characterization of genome integrity for oversized recombinant AAV vector. Dong B; Nakai H; Xiao W Mol Ther; 2010 Jan; 18(1):87-92. PubMed ID: 19904236 [TBL] [Abstract][Full Text] [Related]
2. Characteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection. Nambiar B; Cornell Sookdeo C; Berthelette P; Jackson R; Piraino S; Burnham B; Nass S; Souza D; O'Riordan CR; Vincent KA; Cheng SH; Armentano D; Kyostio-Moore S Hum Gene Ther Methods; 2017 Feb; 28(1):23-38. PubMed ID: 28166648 [TBL] [Abstract][Full Text] [Related]
3. Effect of genome size on AAV vector packaging. Wu Z; Yang H; Colosi P Mol Ther; 2010 Jan; 18(1):80-6. PubMed ID: 19904234 [TBL] [Abstract][Full Text] [Related]
4. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors. Hirsch ML; Wolf SJ; Samulski RJ Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576 [TBL] [Abstract][Full Text] [Related]
5. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238 [TBL] [Abstract][Full Text] [Related]
6. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes. Lieber A; Steinwaerder DS; Carlson CA; Kay MA J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040 [TBL] [Abstract][Full Text] [Related]
7. Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers. Yan Z; Sun X; Feng Z; Li G; Fisher JT; Stewart ZA; Engelhardt JF Hum Gene Ther; 2015 Jun; 26(6):334-46. PubMed ID: 25763813 [TBL] [Abstract][Full Text] [Related]
8. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids. Chamberlain K; Riyad JM; Weber T Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051 [TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Dong JY; Fan PD; Frizzell RA Hum Gene Ther; 1996 Nov; 7(17):2101-12. PubMed ID: 8934224 [TBL] [Abstract][Full Text] [Related]
10. Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity. Wu J; Zhao W; Zhong L; Han Z; Li B; Ma W; Weigel-Kelley KA; Warrington KH; Srivastava A Hum Gene Ther; 2007 Feb; 18(2):171-82. PubMed ID: 17328683 [TBL] [Abstract][Full Text] [Related]
11. Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps. Grieger JC; Samulski RJ J Virol; 2005 Aug; 79(15):9933-44. PubMed ID: 16014954 [TBL] [Abstract][Full Text] [Related]
12. [Novel qPCR strategy for quantification of recombinant adeno-associated virus serotype 2 vector genome-titer]. Meng Q; Zhang B; Zhang C Sheng Wu Gong Cheng Xue Bao; 2013 Feb; 29(2):235-42. PubMed ID: 23697168 [TBL] [Abstract][Full Text] [Related]
13. Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo. Nakai H; Storm TA; Kay MA J Virol; 2000 Oct; 74(20):9451-63. PubMed ID: 11000214 [TBL] [Abstract][Full Text] [Related]
14. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. Nakai H; Yant SR; Storm TA; Fuess S; Meuse L; Kay MA J Virol; 2001 Aug; 75(15):6969-76. PubMed ID: 11435577 [TBL] [Abstract][Full Text] [Related]
15. A helper virus-free packaging system for recombinant adeno-associated virus vectors. Collaco RF; Cao X; Trempe JP Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967 [TBL] [Abstract][Full Text] [Related]
16. Adeno-Associated Virus Vector Mobilization, Risk Versus Reality. Song L; Samulski RJ; Hirsch ML Hum Gene Ther; 2020 Oct; 31(19-20):1054-1067. PubMed ID: 32829671 [TBL] [Abstract][Full Text] [Related]
17. Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo. Wang LN; Wang Y; Lu Y; Yin ZF; Zhang YH; Aslanidi GV; Srivastava A; Ling CQ; Ling C J Integr Med; 2014 Jan; 12(1):20-34. PubMed ID: 24461592 [TBL] [Abstract][Full Text] [Related]
18. Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. Nakai H; Iwaki Y; Kay MA; Couto LB J Virol; 1999 Jul; 73(7):5438-47. PubMed ID: 10364291 [TBL] [Abstract][Full Text] [Related]
19. Consequences of DNA-dependent protein kinase catalytic subunit deficiency on recombinant adeno-associated virus genome circularization and heterodimerization in muscle tissue. Duan D; Yue Y; Engelhardt JF J Virol; 2003 Apr; 77(8):4751-9. PubMed ID: 12663782 [TBL] [Abstract][Full Text] [Related]
20. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV. Fan PD; Dong JY Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]